Association between insulin resistance and breast carcinoma: A systematic review and meta-analysis

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Hernandez, Adrian V ^a,b,c   Guarnizo, Mirella ^a   Miranda, Yony ^a   Pasupuleti, Vinay ^d   Deshpande, Abhishek ^c,d   Paico, Socorro ^a   Lenti, Hosten ^a   Ganoza, Silvia ^a   Montalvo, Laritza ^a   Thota, Priyaleela ^d   Lazaro, Herbert ^a  

^a Instituto Médico de la Mujer   (Peru)

^b UNIVERSIDAD PERUANA DE CIENCIAS APLICADAS   (Peru)

^c LERNER RESEARCH INSTITUTE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; INSULIN;

ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HOMEOSTATIC MODEL ASSESSMENT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SYSTEMATIC REVIEW; BLOOD; BREAST NEOPLASMS; DIET RESTRICTION; META ANALYSIS; METABOLISM; PUBLISHING; RISK;

BREAST NEOPLASMS; C-PEPTIDE; FASTING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; ODDS RATIO; PUBLICATION BIAS;

EID: 84902588444     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099317     Document Type: Article

References (45)

1. American Cancer Society (2014) ACS Cancer Facts and Figures. Cancer Facts and Figures. American Cancer Society.
2. Coughlin SS, Ekwueme DU (2009) Breast cancer as a global health concern. Cancer Epidemiol 33: 315-318.
3. Lebovitz HE (2001) Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes 109 Suppl 2: S135-148.
4. Rinaldi S, Key TJ, Peeters PH, Lahmann PH, Lukanova A, et al. (2006) Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort. Int J Cancer 118: 2832-2839. (Pubitemid 43673364)
5. Tehard B, Lahmann PH, Riboli E, Clavel-Chapelon F (2004) Anthropometry, breast cancer and menopausal status: use of repeated measurements over 10 years of follow-up-results of the French E3N women's cohort study. Int J Cancer 111: 264-269. (Pubitemid 38924705)
6. van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, et al. (2000) Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 152: 514-527.
7. Friedenreich CM, Orenstein MR (2002) Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr 132: 3456S-3464S. (Pubitemid 35315820)
8. Riserus U, Arnlov J, Berglund L (2007) Long-term predictors of insulin resistance: role of lifestyle and metabolic factors in middle-aged men. Diabetes Care 30: 2928-2933. (Pubitemid 350083146)
9. Sachdev D, Yee D (2001) The IGF system and breast cancer. Endocr Relat Cancer 8: 197-209. (Pubitemid 32947642)
10. Kaaks R (2001) [Plasma insulin, IGF-I and breast cancer]. Gynecol Obstet Fertil 29: 185-191.
11. Yam D, Fink A, Mashiah A, Ben-Hur E (1996) Hyperinsulinemia in colon, stomach and breast cancer patients. Cancer Lett 104: 129-132. (Pubitemid 26181001)
12. Fair AM, Dai Q, Shu XO, Matthews CE, Yu H, et al. (2007) Energy balance, insulin resistance biomarkers, and breast cancer risk. Cancer Detect Prev 31: 214-219. (Pubitemid 47248150)
13. Garmendia ML, Pereira A, Alvarado ME, Atalah E (2007) Relation between insulin resistance and breast cancer among Chilean women. Ann Epidemiol 17: 403-409. (Pubitemid 46784023)
14. Eliassen AH, Tworoger SS, Mantzoros CS, Pollak MN, Hankinson SE (2007) Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women. Cancer Epidemiol Biomarkers Prev 16: 161-164. (Pubitemid 46174280)
15. Autier P, Koechlin A, Boniol M, Mullie P, Bolli G, et al. (2013) Serum insulin and C-peptide concentration and breast cancer: a meta-analysis. Cancer Causes Control 24: 873-883.
16. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. (Pubitemid 17189972)
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560. (Pubitemid 37088507)
18. Higgins JP (2008) Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol 37: 1158-1160.
19. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. (Pubitemid 27387172)
20. Bruning PF, Bonfrer JM, van Noord PA, Hart AA, de Jong-Bakker M, et al. (1992) Insulin resistance and breast-cancer risk. Int J Cancer 52: 511-516.
21. Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D, et al. (1998) Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 47: 111-120. (Pubitemid 28046082)
22. Jernstrom H, Barrett-Connor E (1999) Obesity, weight change, fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer: the Rancho Bernardo Study. J Womens Health Gend Based Med 8: 1265-1272. (Pubitemid 30042477)
23. Toniolo P, Bruning PF, Akhmedkhanov A, Bonfrer JM, Koenig KL, et al. (2000) Serum insulin-like growth factor-I and breast cancer. Int J Cancer 88: 828-832.
24. Kaaks R, Lundin E, Rinaldi S, Manjer J, Biessy C, et al. (2002) Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. Cancer Causes Control 13: 307-316. (Pubitemid 34553511)
25. Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR (2002) Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol 156: 349-352. (Pubitemid 34858003)
26. Keinan-Boker L, Bueno De Mesquita HB, Kaaks R, Van Gils CH, Van Noord PA, et al. (2003) Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer. Int J Cancer 106: 90-95. (Pubitemid 36750393)
27. Schairer C, Hill D, Sturgeon SR, Fears T, Pollak M, et al. (2004) Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women. Int J Cancer 108: 773-779. (Pubitemid 38076411)
28. Gonullu G, Ersoy C, Ersoy A, Evrensel T, Basturk B, et al. (2005) Relation between insulin resistance and serum concentrations of IL-6 and TNF-alpha in overweight or obese women with early stage breast cancer. Cytokine 31: 264-269. (Pubitemid 41097362)
29. Falk RT, Brinton LA, Madigan MP, Potischman N, Sturgeon SR, et al. (2006) Interrelationships between serum leptin, IGF-1, IGFBP3, C-peptide and prolactin and breast cancer risk in young women. Breast Cancer Res Treat 98: 157-165. (Pubitemid 44050764)
30. Verheus M, Peeters PH, Rinaldi S, Dossus L, Biessy C, et al. (2006) Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 119: 659-667. (Pubitemid 43955721)
31. Cust AE, Stocks T, Lukanova A, Lundin E, Hallmans G, et al. (2009) The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study. Breast Cancer Res Treat 113: 567-576.
32. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, et al. (2009) Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 101: 48-60.
33. Kabat GC, Kim M, Caan BJ, Chlebowski RT, Gunter MJ, et al. (2009) Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. Int J Cancer 125: 2704-2710.
34. Capasso I, Esposito E, Pentimalli F, Crispo A, Montella M, et al. (2010) Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience. Cancer Biol Ther 10: 1240-1243.
35. Sieri S, Muti P, Claudia A, Berrino F, Pala V, et al. (2012) Prospective study on the role of glucose metabolism in breast cancer occurrence. Int J Cancer 130: 921-929.
36. Lawlor DA, Smith GD, Ebrahim S (2004) Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women's Heart and Health Study. Cancer Causes Control 15: 267-275. (Pubitemid 38988035)
37. Abbasi M, Tarafdari A, Esteghamati A, Vejdani K, Nakhjavani M (2010) Insulin resistance and breast carcinogenesis: a cross-sectional study among Iranian women with breast mass. Metab Syndr Relat Disord 8: 411-416.
38. Tran TT, Medline A, Bruce WR (1996) Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev 5: 1013-1015. (Pubitemid 26415875)
39. Tsugane S, Inoue M (2010) Insulin resistance and cancer: epidemiological evidence. Cancer Sci 101: 1073-1079.
40. Rose DP, Haffner SM, Baillargeon J (2007) Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women. Endocr Rev 28: 763-777. (Pubitemid 350294295)
41. Xue F, Michels KB (2007) Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 86: s823-835.
42. Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D (2012) Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care 35: 2402-2411.
43. Ford ES, Giles WH (2003) A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 26: 575-581. (Pubitemid 36929310)
44. Friedenreich CM, Langley AR, Speidel TP, Lau DC, Courneya KS, et al. (2012) Case-control study of markers of insulin resistance and endometrial cancer risk. Endocr Relat Cancer 19: 785-792.
45. Gnagnarella P, Gandini S, La Vecchia C, Maisonneuve P (2008) Glycemic index, glycemic load, and cancer risk: a meta-analysis. Am J Clin Nutr 87: 1793-1801. (Pubitemid 351872644)